These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8740529)

  • 21. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zatebradine slows ectopic ventricular rhythms in canine heart 24 hours after coronary artery ligation.
    Lasker SM; Han D; Kline RP
    J Cardiovasc Pharmacol; 1997 May; 29(5):662-9. PubMed ID: 9213210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.
    Hu K; Naumann A; Fraccarollo D; Gaudron P; Kaden JJ; Neubauer S; Ertl G
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1281-8. PubMed ID: 15020301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind placebo-controlled evaluation of the human electrophysiologic effects of zatebradine, a sinus node inhibitor.
    Chiamvimonvat V; Newman D; Tang A; Green M; Mitchell J; Wulffhart Z; Dorian P
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):516-20. PubMed ID: 9781918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart.
    Kalman JM; Tonkin AM; Power JM
    J Pharmacol Exp Ther; 1995 Jan; 272(1):85-93. PubMed ID: 7815369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive inotropic and lusitropic effects of triiodothyronine in conscious dogs with pacing-induced cardiomyopathy.
    Jamall IN; Pagel PS; Hettrick DA; Lowe D; Kersten JR; Tessmer JP; Warltier DC
    Anesthesiology; 1997 Jul; 87(1):102-9. PubMed ID: 9232140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of excitation-contraction coupling in conscious dogs with pacing-induced heart failure.
    Neumann T; Ravens U; Heusch G
    Cardiovasc Res; 1998 Feb; 37(2):456-66. PubMed ID: 9614500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of changing heart rate on electrophysiological and hemodynamic function in the dog.
    Hamlin RL; Nakayama T; Nakayama H; Carnes CA
    Life Sci; 2003 Mar; 72(17):1919-30. PubMed ID: 12597991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of atrial fibrillation on left ventricle function in the elderly].
    Wysokiński A; Zapolski T
    Pol Arch Med Wewn; 2005 Mar; 113(3):223-30. PubMed ID: 16128279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of sinus node depression on heart rate variability in humans using zatebradine, a selective bradycardic agent.
    Khaykin Y; Dorian P; Tang A; Green M; Mitchell J; Wulffhart Z; Newman D
    Can J Physiol Pharmacol; 1998; 76(7-8):806-10. PubMed ID: 10030463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
    Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
    Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
    Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
    Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UL-FS 49 (zatebradine) does not affect arterial baroreflex in conscious normal or aortic-constricted rats.
    Sakamoto M; Siri FM; Solomon SB; Tanimoto H; Yellin EL
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):488-92. PubMed ID: 9554794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):59-65. PubMed ID: 1576097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute biventricular hemodynamic effects of cardiac resynchronization therapy in right bundle branch block.
    Houston BA; Sturdivant JL; Yu Y; Gold MR
    Heart Rhythm; 2018 Oct; 15(10):1525-1532. PubMed ID: 29800750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.